1.Shi, T et al. (2017) Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet 390, 946–958.
2.Bont, L et al. (2016) Defining the epidemiology and burden of severe respiratory syncytial virus infection among infants and children in Western Countries. Infectious Diseases & Therapy 5, 271–298.
3.Homaira, N et al. (2016) High burden of RSV hospitalization in very young children: a data linkage study. Epidemiology and Infection 144, 1612–1621.
4.Jepsen, MT et al. (2018) Incidence and seasonality of respiratory syncytial virus hospitalisations in young children in Denmark, 2010 to 2015. Euro Surveillance 23, 3.
5.Reeves, RM et al. (2017) Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007–2012. Influenza Other Respiratory Viruses 11, 122–129.
6.Reeves, RM et al. (2019) Burden of hospital admissions caused by respiratory syncytial virus (RSV) in infants in England: a data linkage modelling study. Journal of Infection 78, 468–475.
7.Reis, AD et al. (2008) Comparison of direct immunofluorescence, conventional cell culture and polymerase chain reaction techniques for detecting respiratory syncytial virus in nasopharyngeal aspirates from infants. Revista do Instituto de Medicina Tropical de São Paulo 50, 37–40.
8.Vogel, A et al. (2002) Cost-effectiveness of palivizumab in New Zealand. Journal of Paediatrics and Child Health 38, 352–357.
10.Huang, QS et al. (2015) Southern hemisphere influenza and vaccine effectiveness research and surveillance. Influenza and Other Respiratory Viruses 9, 179–190.
13.Prasad, N et al. (2018) Interactive effects of age and respiratory virus on severe lower respiratory infection. Epidemiology and Infection 146, 1861–1869.
14.Kim, C et al. (2011) Comparison of nasopharyngeal and oropharyngeal swabs for the diagnosis of eight respiratory viruses by real-time reverse transcription-PCR assays. PLoS ONE 6, e21610.
15.Shu, B et al. (2011) Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A (H1N1) pandemic influenza virus. Journal of Clinical Microbiology 49, 2614–2619.
16.Szewczuk, E et al. (2010) Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness. BMC Infectious Diseases 10, 113.
20.Jansson, L, Nilsson, P and Olsson, M (2002) Socioeconomic environmental factors and hospitalization for acute bronchiolitis during infancy. Acta Paediatrica 91, 335–338.
21.Karron, RA et al. (1999) Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group. Journal of Infectious Diseases 180, 41–49.
22.Atkinson, J, Salmond, C and Crampton, P (2014) .
23.Tobias, M, Bhattacharya, A and White, P (2008) Cross classification of the New Zealand population by ethnicity and deprivation: trends from 1996 to 2006. Australian and New Zealand Journal of Public Health 32, 431–436.
24.Little, RJ (1988) A test of missing completely at random for multivariate data with missing values. Journal of the American Statistical Association 83, 1198–1202.
25.Trenholme, AA et al. (2017) Respiratory virus detection during hospitalisation for lower respiratory tract infection in children under 2 years in South Auckland, New Zealand. Journal of Paediatrics and Child Health 53, 551–555.
27.Milne, RJ and Grimwood, K (2009) Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Value in Health 12, 888–898.
28.Grimwood, K et al. (2006) Rotavirus hospitalisation in New Zealand children under 3 years of age. Journal of Paediatrics and Child Health 42, 196–203.
29.Hobbs, MR et al. (2017) Ethnic disparities in infectious disease hospitalisations in the first year of life in New Zealand. Journal of Paediatrics and Child Health 53, 223–231.
30.Hall, CB et al. (2009) The burden of respiratory syncytial virus infection in young children. New England Journal of Medicine 360, 588–598.
31.Cheung, CR et al. (2013) Population variation in admission rates and duration of inpatient stay for bronchiolitis in England. Archives of Disease in Childhood 98, 57–59.
32.Grant, CC et al. (1998) Hospitalization for pneumonia in children in Auckland, New Zealand. Journal of Paediatrics and Child Health 34, 355–359.
33.Griffin, MR et al. (2013) US hospitalizations for pneumonia after a decade of pneumococcal vaccination. New England Journal of Medicine 369, 155–163.
34.Hasegawa, K et al. (2013) Trends in bronchiolitis hospitalizations in the United States, 2000–2009. Pediatrics 132, 28–36.
36.Holman, RC et al. (2004) Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics 114, e437–e444.
37.Baker, MG et al. (2012) Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study. Lancet 379, 1112–1119.
38.Baker, M et al. (2013) Infectious Diseases Attributable to Household Crowding in New Zealand: A Systematic Review and Burden of Disease Estimate. Wellington: He Kainga Oranga/Housing and Health Research.
39.Grant, CC et al. (2011) Primary care practice and health professional determinants of immunisation coverage. Journal of Paediatrics and Child Health 47, 541–549.
40.Petousis-Harris, H et al. (2018) Pneumococcal conjugate vaccines turning the tide on inequity – a retrospective cohort study of New Zealand children born 2006–2015. Clinical Infectious Diseases, ciy570–ciy570.
41.Lennon, D et al. (2012) Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemic. Journal of Paediatrics and Child Health 48, 193–201.